Pozna n University School of the Medical Sciences, Pozna n, Poland BACKGROUND Vascular complications remain the most frequent complication and significantly affect the procedural results of TAVI. METHODS From September 2010 to January 2015, 108 consecutive patients underwent TAVI in our department. Of them, femoral access was obtained in 100 patients, direct aorta in 4 patients and transapical in 4 patients. All 100 patients with femoral access were included to the final analysis. Femoral artery anatomy-tailored program was introduced in 2013 in our center in order to reduce the rate of access-site vascular complications in TAVI patients. The main goal was to find an optimal vessel morphology for safe percutaneous approach. The following angio-CT findings were considered a high risk for percutaneous approach: 1. Severe calcifications at the puncture site 2. Diffuse atherosclerotic disease with a large plaque burden 3. Inability to perform contralateral injection-controlled puncture. All patients with such characteristics were pre-planned to surgical cut-down approach. The study cohort was divided into two subgroups: group A -patients treated between September 2010 to December 2012 before introduction of the tailored vascular access program (n¼35) and group B -patients treated from January 2013 till December 2014 (n¼65). All patients in group A were treated with percutaneous puncture and device closure. Group B comprised of 47 patients with percutaneous access and 18 patients in whom surgical approach was chosen. RESULTS A total of 100 patients (mean age 79.6AE6.5, range 57 to 91, 46% male) with femoral access were included to the analysis. The CoreValve prosthesis was implanted in 95 patents (95%) and Lotus in 4 patients (4%). In one case the prosthesis was not implanted because the patient died during procedure after wire positioning. In one patient with Prostar closure the device could not be successfully closed and the artery was closed in the surgical manner. Vascular access site complication rate significantly decreased from 34,3% in the group A (n¼12) to 6,2% in the group B (n¼4) (p¼0,0005). Both minor and major access complications were more frequent in the group A than in the group B, and the result was statistically significant (p¼0,03 and 0,02, respectively). Both groups did not differ much in terms of baseline characteristics and risk evaluated on the basis of risk score calculators. Arterial hypertension and prior myocardial infarction were more common in the group B. In-hospital mortality was 11,4% (n¼4) in the group A and 1,5% (n¼1) in the group B (p¼0,05). Two deaths were related to access site complications in the group A, one in the group B. CONCLUSIONS The introduction of tailored vascular access program resulted in significant reduction in both minor and access site complications. The pre-procedural access screening with qualification to closure-device or surgical cutdown technique seems to be the most important step to reduce the vascular complication rate. . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5
